Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound ...

CVS will exit Obamacare plans in 2026, affecting 1 million members across 17 states, and close stores amid pharmacy desert ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest ... that are hired by employers to oversee prescription coverage for Americans.

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss ... by CVS Health’s pharmacy benefits management business, which runs prescription ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss ... patients cannot afford to pay for on their own. The formulary is maintained by CVS ...

CVS Caremark to list Wegovy as preferred ... This new offering builds on Hims & Hers' existing suite of weight loss solutions and provides self-pay patients with access to all dose strengths ...